[go: up one dir, main page]

ZA917627B - Pharmaceutical composition in gel form in a dispensing package - Google Patents

Pharmaceutical composition in gel form in a dispensing package

Info

Publication number
ZA917627B
ZA917627B ZA917627A ZA917627A ZA917627B ZA 917627 B ZA917627 B ZA 917627B ZA 917627 A ZA917627 A ZA 917627A ZA 917627 A ZA917627 A ZA 917627A ZA 917627 B ZA917627 B ZA 917627B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical composition
gel form
dispensing package
pharmaceutical
composition
Prior art date
Application number
ZA917627A
Other languages
English (en)
Inventor
Pierre Tachon
Tachon Pierre
Beatrice Vagneur
Vagneur Beatrice
Jean-Louis Viret
Viret Jean-Louis
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of ZA917627B publication Critical patent/ZA917627B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • External Artificial Organs (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ZA917627A 1990-10-04 1991-09-24 Pharmaceutical composition in gel form in a dispensing package ZA917627B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90118920 1990-10-04

Publications (1)

Publication Number Publication Date
ZA917627B true ZA917627B (en) 1992-06-24

Family

ID=8204572

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA917627A ZA917627B (en) 1990-10-04 1991-09-24 Pharmaceutical composition in gel form in a dispensing package

Country Status (27)

Country Link
US (2) US5300302A (xx)
EP (1) EP0479005B1 (xx)
JP (1) JP3219799B2 (xx)
KR (1) KR100213513B1 (xx)
AT (1) ATE131039T1 (xx)
AU (1) AU643067B2 (xx)
BR (1) BR9104280A (xx)
CA (1) CA2052615C (xx)
DE (1) DE69115210T2 (xx)
DK (1) DK0479005T3 (xx)
DZ (1) DZ1530A1 (xx)
EG (1) EG19906A (xx)
ES (1) ES2081407T3 (xx)
FI (1) FI104947B (xx)
GR (1) GR3018893T3 (xx)
HU (1) HU219222B (xx)
IE (1) IE72146B1 (xx)
IL (1) IL99509A (xx)
MA (1) MA22289A1 (xx)
MX (1) MX9101391A (xx)
MY (1) MY107488A (xx)
NO (1) NO303525B1 (xx)
NZ (1) NZ240068A (xx)
PT (1) PT99143B (xx)
RU (1) RU2093143C1 (xx)
TN (1) TNSN91085A1 (xx)
ZA (1) ZA917627B (xx)

Families Citing this family (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300302A (en) * 1990-10-04 1994-04-05 Nestec S.A. Pharmaceutical composition in gel form in a dispensing package
MX9304638A (es) * 1992-07-31 1994-05-31 Neose Pharm Inc Composicion para tratar e inhibir las ulceras gastricas y duodenales.
JPH06172189A (ja) * 1992-08-17 1994-06-21 Bristol Myers Squibb Co 胃腸保護複合剤
IL108366A (en) * 1993-03-11 1999-11-30 Taro Vit Ind Ltd Semi-solid pharmaceutical compounds and a device for their use
US5881926A (en) * 1993-03-11 1999-03-16 Taro Pharmaceutical Industries, Ltd. Pharmaceutical compositions in semisolid form and a device for administration thereof
WO1996011162A1 (en) * 1994-10-11 1996-04-18 Monson James A Dispensing apparatus for foaming compositions and method
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
ATE197900T1 (de) * 1996-08-15 2000-12-15 Losan Pharma Gmbh Gut schluckbare orale arzneiform
US5759579A (en) * 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
US6071523A (en) * 1998-06-03 2000-06-06 Taro Pharmaceuticals Industries, Ltd. Spill resistant pharmaceutical compositions in semi-solid form
US7919109B2 (en) 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
KR100399483B1 (ko) * 2000-12-12 2003-09-29 대화제약 주식회사 플로로글루시놀을 유효성분으로 함유하는 신규 진경액제
NZ529490A (en) * 2001-06-22 2005-08-26 Pfizer Prod Inc Pharmaceutical compositions of adsorbates of amorphous drug
JP2004537566A (ja) * 2001-08-01 2004-12-16 ブリストル−マイヤーズ　スクイブ　カンパニー 味マスキング組成物
US7638150B2 (en) * 2002-08-02 2009-12-29 Simply Thick Llp Process for preparing concentrate thickener compositions
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
US20030235618A1 (en) * 2001-10-22 2003-12-25 Taro Pharmaceutical Industries Ltd. Taste masking spill-resistant formulation
JP2005506993A (ja) * 2001-10-22 2005-03-10 タロ ファーマシューティカル インダストリーズ リミテッド 味マスキングこぼれ抵抗性組成物
US20050143471A1 (en) * 2001-10-22 2005-06-30 Shen Gao Taste masking spill-resistant formulation
WO2003049593A2 (en) * 2001-12-06 2003-06-19 Duke University Prevention of flap necrosis in plastic surgery
RU2199309C1 (ru) * 2001-12-29 2003-02-27 Закрытое акционерное общество "Брынцалов-А" Лекарственное средство нобрассит седативного и анксиолитического действия
ES2305434T3 (es) 2002-02-01 2008-11-01 Pfizer Products Inc. Composiciones framaceuticas de dispersiones amorfas de farmacos y materiales que forman microfases lipofilas.
RU2206322C1 (ru) * 2002-02-18 2003-06-20 Акционерное Курганское общество медицинских препаратов и изделий "Синтез" Лекарственное средство, обладающее болеутоляющим и жаропонижающим действием
US20030166732A1 (en) * 2002-02-27 2003-09-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
AU2003238221A1 (en) * 2002-06-17 2003-12-31 Taro Pharmaceuticals U.S.A, Inc. Ibuprofen suspension
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US8481000B2 (en) * 2003-01-31 2013-07-09 Simply Thick, Llc Thickened beverages for dysphagia
CA2532931A1 (en) * 2003-08-04 2005-02-10 Pfizer Products Inc. Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials
US7201920B2 (en) * 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
WO2005105102A1 (en) * 2004-05-04 2005-11-10 Equitech Corporation Improved nsaid composition
CA2916869A1 (en) 2004-06-12 2005-12-29 Jane C. Hirsh Abuse-deterrent drug formulations
RU2276979C2 (ru) * 2004-06-21 2006-05-27 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтический состав антидиарейного действия
MX2007006253A (es) * 2004-11-24 2007-10-18 Anesiva Inc Formulacion de gel de capsaicinoide y usos para esta.
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
US10042980B2 (en) * 2005-11-17 2018-08-07 Gearbox Llc Providing assistance related to health
US20070119928A1 (en) * 2005-11-17 2007-05-31 Jung Edward K Generating a nutraceutical request from an inventory
US8468029B2 (en) * 2005-11-17 2013-06-18 The Invention Science Fund I, Llc Subscriptions for assistance related to health
US20070112589A1 (en) * 2005-11-17 2007-05-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware User interface for providing assistance related to health
US20070112592A1 (en) * 2005-11-17 2007-05-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Payments in providing assistance related to health
US8532938B2 (en) * 2005-11-17 2013-09-10 The Invention Science Fund I, Llc Testing-dependent administration of a nutraceutical
US20080004909A1 (en) * 2005-11-30 2008-01-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems related to nutraceuticals
US20080033763A1 (en) * 2005-11-30 2008-02-07 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems related to receiving nutraceutical associated information
US8068991B2 (en) * 2005-11-30 2011-11-29 The Invention Science Fund I, Llc Systems and methods for transmitting pathogen related information and responding
US8297028B2 (en) * 2006-06-14 2012-10-30 The Invention Science Fund I, Llc Individualized pharmaceutical selection and packaging
US8340944B2 (en) * 2005-11-30 2012-12-25 The Invention Science Fund I, Llc Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US20070124219A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized nutraceutical selection and packaging
US20070174128A1 (en) * 2005-11-30 2007-07-26 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US20080193919A1 (en) * 2005-11-30 2008-08-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems and methods for receiving pathogen related information and responding
US7927787B2 (en) 2006-06-28 2011-04-19 The Invention Science Fund I, Llc Methods and systems for analysis of nutraceutical associated components
US20080004905A1 (en) * 2006-06-28 2008-01-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for analysis of nutraceutical associated components
US10296720B2 (en) * 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US20070136092A1 (en) * 2005-11-30 2007-06-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US20080114577A1 (en) * 2005-11-30 2008-05-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational methods and systems associated with nutraceutical related assays
US20110145009A1 (en) * 2005-11-30 2011-06-16 Jung Edward K Y Methods and systems related to transmission of nutraceutical associatd information
US8000981B2 (en) * 2005-11-30 2011-08-16 The Invention Science Fund I, Llc Methods and systems related to receiving nutraceutical associated information
US20080082272A1 (en) * 2005-11-30 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods related to nutraceuticals
US20070289258A1 (en) * 2006-06-14 2007-12-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Individualized pharmaceutical selection and packaging
US20070124176A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US7974856B2 (en) * 2005-11-30 2011-07-05 The Invention Science Fund I, Llc Computational systems and methods related to nutraceuticals
US7827042B2 (en) * 2005-11-30 2010-11-02 The Invention Science Fund I, Inc Methods and systems related to transmission of nutraceutical associated information
US20080052114A1 (en) * 2005-11-30 2008-02-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods related to nutraceuticals
WO2007075378A2 (en) * 2005-12-20 2007-07-05 Searete Llc Control systems for individualized pharmaceutical and nutraceutical selection and packaging
MY157620A (en) 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
MX2008014870A (es) 2006-05-30 2009-02-12 Intarcia Therapeutics Inc Modulador de flujo para sistema de suministro osmotico con canal interno de dos piezas.
US20080086338A1 (en) * 2006-06-23 2008-04-10 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Customized visual marking for medication labeling
US20070299695A1 (en) * 2006-06-23 2007-12-27 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Customized visual marking for medication labeling
US20080086339A1 (en) * 2006-06-23 2008-04-10 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Customized visual marking for medication labeling
MX2009001114A (es) 2006-08-09 2009-02-10 Intarcia Therapeutics Inc Sistemas de suministro osmotico y ensambles de piston.
RU2323005C1 (ru) * 2006-12-12 2008-04-27 ООО "РесурсМетод" Способ получения ксантанового загустителя "сараксан" или "сараксан-т"
KR20080076667A (ko) 2007-02-15 2008-08-20 주식회사 중외제약 요변성 약학 조성물
CN104000779A (zh) 2007-04-23 2014-08-27 精达制药公司 促胰岛素释放肽的混悬制剂及其应用
US8445044B2 (en) * 2007-05-07 2013-05-21 Kent Precision Foods Group, Inc. Food thickening agent, method for producing food thickening agent
US8001345B2 (en) * 2007-05-10 2011-08-16 Dot Hill Systems Corporation Automatic triggering of backing store re-initialization
DK2170283T3 (en) 2007-06-22 2019-04-15 Univ Texas CREATION OF STABLE SUBMICRON Peptide OR PROTEIN PARTICLES BY THIN FILM FREEZING
GB0714670D0 (en) * 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) * 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
CA2726861C (en) 2008-02-13 2014-05-27 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
GB0818473D0 (en) 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition
JP5711138B2 (ja) 2008-11-16 2015-04-30 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム 高濃度の低粘度懸濁液
US8658628B2 (en) * 2009-06-18 2014-02-25 Karan Y. Baucom Hormone delivery system and method
US9795617B2 (en) 2009-06-18 2017-10-24 Baucom Institute for Longevity and Life Enhancement, Inc. Hormone delivery system and method
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
DK2462246T3 (da) 2009-09-28 2017-11-06 Intarcia Therapeutics Inc Hurtig etablering og/eller afslutning af væsentlig steady-state-lægemiddelafgivelse
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition
KR101572336B1 (ko) 2010-12-22 2015-11-26 퍼듀 퍼머 엘피 케이싱된 탬퍼 저항성 제어 방출 투여 형태
PH12013501345A1 (en) 2010-12-23 2022-10-24 Purdue Pharma Lp Tamper resistant solid oral dosage forms
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9370177B2 (en) 2011-12-22 2016-06-21 Babolna Bio Ltd. Consumable aqueous gel for use in pest control, a pest control device comprising an aqueous gel, and the use of an aqueous gel in a pest control device and in a method of controlling pests
DK2911530T3 (en) * 2012-10-25 2017-03-20 Nestec Sa INCORPORATED BITTER PEPTIDES, PROCEDURES FOR ENCOURAGING BITTER PEPTIDES, AND NUTRITIONAL COMPOSITIONS INCLUDING THE CONTAINED BITTER PEPTIDES
US8550131B1 (en) 2013-01-02 2013-10-08 Liquid Squeeze, LLC Liquid dispensing device, system and method
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
US9101156B2 (en) 2013-03-15 2015-08-11 Kent Precision Foods Group, Inc. Thickener composition, thickened nutritive products, methods for preparing thickened nutritive products, and methods for providing nutrition
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
US10925639B2 (en) 2015-06-03 2021-02-23 Intarcia Therapeutics, Inc. Implant placement and removal systems
CA2991719C (en) * 2015-07-09 2023-07-04 Uniwell Laboratories Llc Pharmaceutical compositions
MA53353A (fr) 2016-05-16 2021-06-09 Intarcia Therapeutics Inc Polypeptides sélectifs pour le récepteur du glucagon et méthodes pour leur utilisation
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
KR20190104039A (ko) 2017-01-03 2019-09-05 인타르시아 세라퓨틱스 인코포레이티드 Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법
US11751594B2 (en) 2020-10-22 2023-09-12 Grain Processing Corporation Food thickener composition and method

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767784A (en) * 1970-12-01 1973-10-23 S Gluck Composition for the protection and treatment of injured body tissue and method of utilizing the same
US4155741A (en) * 1974-05-01 1979-05-22 Stauffer Chemical Company Stable suspension system for microencapsulated flowable formulations, and method of preparing stable suspension of microcapsules
US4136177A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
US4305933A (en) * 1980-03-10 1981-12-15 Wiczer Sol B Thickened gelatinous edible alcoholic medicated carrier
US4424055A (en) * 1981-12-18 1984-01-03 Herman Wesley K Irrigation and aspiration syringe
EP0084638B1 (de) 1982-01-19 1987-12-23 Gap Gesellschaft Für Auswertungen Und Patente Ag Spender für pastöse Produkte
US4427681A (en) * 1982-09-16 1984-01-24 Richardson-Vicks, Inc. Thixotropic compositions easily convertible to pourable liquids
USRE32969E (en) * 1982-10-14 1989-06-27 Injectionable visoelastic ophthalmic gel
US4576645A (en) * 1984-12-06 1986-03-18 Block Drug Co., Inc. Whipped gel composition
IT1183574B (it) * 1985-05-08 1987-10-22 Eurand Spa Metodo per ottenere una sospensione estemporanea omogenea di microcapsule
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
IT1234194B (it) * 1988-05-31 1992-05-06 Magis Farmaceutici Composizioni farmaceutiche in forma di sciroppo contenenti pentitoli quali agenti di veicolazione
US5288479A (en) * 1989-01-17 1994-02-22 Sterling Drug, Inc. Extrudable elastic oral pharmaceutical gel compositions and metered dose dispensers containing them and method of making and method of use thereof
US5215739A (en) * 1989-04-05 1993-06-01 Toko Yakuhin Kogyo Kabushiki Kaisha Spray gel base and spray gel preparation using thereof
US4994277A (en) * 1989-10-31 1991-02-19 Pfizer Hospital Products Group, Inc. Use of xanthan gum for preventing adhesions
US5300302A (en) * 1990-10-04 1994-04-05 Nestec S.A. Pharmaceutical composition in gel form in a dispensing package

Also Published As

Publication number Publication date
AU643067B2 (en) 1993-11-04
DE69115210T2 (de) 1996-05-09
NO913847D0 (no) 1991-10-01
ATE131039T1 (de) 1995-12-15
PT99143B (pt) 1999-04-30
DK0479005T3 (da) 1996-03-11
IL99509A0 (en) 1992-08-18
NZ240068A (en) 1994-05-26
JP3219799B2 (ja) 2001-10-15
NO303525B1 (no) 1998-07-27
IE72146B1 (en) 1997-03-26
DZ1530A1 (fr) 2002-02-17
MA22289A1 (fr) 1992-04-01
AU8458991A (en) 1992-04-09
NO913847L (no) 1992-04-06
EP0479005B1 (fr) 1995-12-06
MY107488A (en) 1995-12-30
IE913286A1 (en) 1992-04-08
HU219222B (en) 2001-03-28
TNSN91085A1 (fr) 1992-10-25
KR920007621A (ko) 1992-05-27
FI914607A0 (fi) 1991-10-01
FI104947B (fi) 2000-05-15
CA2052615A1 (en) 1992-04-05
DE69115210D1 (de) 1996-01-18
EG19906A (fr) 1996-05-31
PT99143A (pt) 1993-12-31
BR9104280A (pt) 1992-06-02
US5505959A (en) 1996-04-09
RU2093143C1 (ru) 1997-10-20
HU912990D0 (en) 1992-01-28
FI914607L (fi) 1992-04-05
CA2052615C (en) 2001-01-16
EP0479005A1 (fr) 1992-04-08
ES2081407T3 (es) 1996-03-01
IL99509A (en) 1995-08-31
HUT59587A (en) 1992-06-29
KR100213513B1 (ko) 1999-08-02
MX9101391A (es) 1992-04-01
JPH04247023A (ja) 1992-09-03
GR3018893T3 (en) 1996-05-31
US5300302A (en) 1994-04-05

Similar Documents

Publication Publication Date Title
ZA917627B (en) Pharmaceutical composition in gel form in a dispensing package
AU5541594A (en) Vaginal sponge delivery system
GB2265088B (en) Electrochemical device for drug delivery
GR3036622T3 (en) Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds
AU8538991A (en) Delivery device for atomized medicaments
AU555061B2 (en) Sustained release oral medicinal delivery device
IT8947938A0 (it) Adsorbati di resina, procedimento per prepararli e composizioni farmaceutiche che li contengono
IL117706A0 (en) Powdered drug storage and delivery system
NZ280610A (en) Soft gelatin-like pharmaceutical carrier: gelled polyethylene glycol and dispersed active agent
PT1207809E (pt) Medição e empacotamento de medicamento de libertação controlada
ES8705240A1 (es) Dispositivo osmotico para la administracion controlada de unagente benefico a un ambiente de utilizacion
ES2060040T5 (es) Dispositivo y formulacion de inhalacion de medicamento.
EG20670A (en) Active substance delivery system
IL141914A0 (en) Dosage form comprising liquid formulation
GB9226691D0 (en) Dental active delivery system
ZA902066B (en) Solid gel external drug delivery system
AU7238896A (en) High capacity, superabsorbent drug reservoirs for use in transdermal drug delivery systems
GB9325292D0 (en) Polymeric delivery system for the periodontal pocket
CA2185883A1 (en) The use of dimeticone as a transport and carrier system and/or drug delivery system
DE59510583D1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
EP0595226A3 (en) Active substance-containing polymer gel
HUT75711A (en) The use of dimeticone as a transport and carrier system and/or drug delivery system, and pharmaceutical compositions containing dimeticone
CA2249637A1 (en) Uniform drug delivery therapy
EP0408019A3 (en) Pharmaceutical active derivative delivery systems
DE3379862D1 (en) Osmotic drug delivery device